Polycystic ovary syndrome and cardiovascular disease: a premature association?

Cited by (465)

Items 201–300 of 465

1. Relationship of Polycystic Ovarian Syndrome with Cardiovascular Risk Factors
   Muhammad Bilal, Abdul Haseeb, Abdur Rehman · 2018 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
2. How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome?
   Manfredi Rizzo, Kaspar K. Berneis, Enrico Carmina, Giovam Battista Rini · 2008 · American Journal of Obstetrics and Gynecology
3. The Effect of Metformin Treatment on the Serum Levels of Homocysteine, Folic Acid, and Vitamin B12 in Patients with Polycystic Ovary Syndrome
   Sedighe Esmaeilzadeh, Maryam Gholinezhad, Reza Ghadimi · 2017 · Journal of Human Reproductive Sciences
4. Association of polycystic ovary syndrome with cardiovascular disease among female hospitalizations in the United States
   Alok Kumar Dwivedi, Deepanjali Vishwakarma, Pallavi Dubey, Sireesha Reddy · 2023 · European Journal of Endocrinology
5. Prevalence of abnormalities of glucose metabolism in patients with polycystic ovary syndrome
   Cristiano Roberto Grimaldi Barcellos, Michelle P. Rocha, Sylvia Asaka Yamashita Hayashida, Márcia Nery, José Antônio Miguel Marcondes · 2007 · Arquivos Brasileiros de Endocrinologia & Metabologia
6. Combined Oral Contraceptives in Polycystic Ovary Syndrome – Indications and Cautions
   Gürkan Bozdağ, Bülent Okan Yıldız · 2012 · Frontiers of hormone research
7. Drospirenone and cardiovascular risk in lean and obese polycystic ovary syndrome patients: a pilot study
   Fulvia Mancini, Arianna Cianciosi, Nicola Persico, Fabio Facchinetti, Paolo Busacchi, Cesare Battaglia · 2009 · American Journal of Obstetrics and Gynecology
8. Simvastatin Effects on Androgens, Inflammatory Mediators, and Endogenous Pituitary Gonadotropins among Patients with PCOS Undergoing IVF: Results from a Prospective, Randomized, Placebo-Controlled Clinical Trial
   Batool Hossein Rashidi, Jhila Abediasl, Ensiyeh Shahrokh Tehraninejad, Haleh Rahmanpour, Eric Scott Sills · 2011 · Journal of Investigative Medicine
9. Plasma levels of pentraxin-3, an inflammatory protein involved in fertility, are reduced in women with polycystic ovary syndrome
   Flavia Tosi, Daniela Di Sarra, Cecilia Bonin, Francesca Zambotti, Marlene Dall'Alda, Tom Fiers, Jean‐Marc Kaufman, Matilde Donati, Massimo Piergiuseppe Franchi, Maria Elisabetta Zanolin et al. · 2013 · European Journal of Endocrinology
10. Prevalence of polycystic ovary syndrome in reproductive-aged women with type 2 diabetes
    Massoud Amini, Negar Horri, Mahboubeh Farmani, Sassan Haghighi, Ghoshtasb Sattari, Zahra Pornaghshband, Ashraf Aminorroaya · 2008 · Gynecological Endocrinology
11. Clustering of Cardiovascular Risk Factors Associated With the Insulin Resistance Syndrome
    Maria Elisabetta Zanolin, Flavia Tosi, Giacomo Zoppini, Roberto Castello, Giovanna Spiazzi, Romolo Marco Dorizzi, Michele Muggeo, Paolo Moghetti · 2006 · Diabetes Care
12. Normal cut-off values for hyperandrogenaemia in Iranian women of reproductive age
    Somayeh Hashemi, Fahimeh Ramezani Tehrani, Mahsa Noroozzadeh, Fereidoun Azizi · 2013 · European Journal of Obstetrics & Gynecology and Reproductive Biology
13. Practice patterns of screening for sleep apnea in physicians treating PCOS patients
    Shyam Subramanian, Ashesh D. Desai, Mohit Joshipura, Salim Surani · 2007 · Sleep And Breathing
14. The Polycystic Ovary Syndrome: Current Concepts On Pathogenesis And Clinical Care
    Ricardo Azziz · 2007 · Springer eBooks
15. Polymorphism of the interleukin‐10 gene in polycystic ovary syndrome
    M. Karadeniz, M. Erdogan, Ayhan Zengi, Sadık Tamsel, Afig Berdelı, Füsun Saygılı, C. Yilmaz · 2008 · International Journal of Immunogenetics
16. Do ACE I/D gene polymorphism serve as a predictive marker for age at onset in PCOS?
    M. Deepika, K. Ranjith Reddy, V. Usha Rani, Nagalla Balakrishna, K. Prasanna Latha, Parveen Jahan · 2012 · Journal of Assisted Reproduction and Genetics
17. Irregular Cycles, Ovulatory Disorders, and Cardiometabolic Conditions in a US-Based Digital Cohort
    Zifan Wang, Anne Marie Z. Jukic, Donna D. Baird, Allen James Wilcox, Huichu Li, Christine L. Curry, Tyler Fischer‐Colbrie, Jukka-Pekka “JP” Onnela, Michelle Anne Williams, Russ B. Hauser et al. · 2024 · JAMA Network Open
18. Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities
    Jana Figurová, Ingrid Dravecká, Martin Javorský, Jana Petríková, Ivica Lazúrová · 2015 · Wiener klinische Wochenschrift
19. Association between the Pro12Ala polymorphism of PPAR-γ gene and the polycystic ovary syndrome: A meta-analysis of case–control studies
    Hong Zhang, Yan Bi, Changjun Hu, Weiping Lu, Dalong Zhu · 2012 · Gene
20. The therapeutic potential of somatostatin receptor ligands in the treatment of obesity and diabetes
    Bernhard Otto Boehm · 2003 · Expert Opinion on Investigational Drugs
21. High sensitivity C-reactive protein and its relationship with impaired glucose regulation in lean patients with polycystic ovary syndrome
    Ji Won Kim, Ji Eun Han, You Shin Kim, Hyung Jae Won, Tae Ki Yoon, Woo Sik Lee · 2011 · Gynecological Endocrinology
22. Frequency of nodular goiter and autoimmune thyroid disease and association of these disorders with insulin resistance in polycystic ovary syndrome
    Melia Karaköse, Sema Hepşen, Erman Çakal, Müyesser Saykı Arslan, Esra Tutal, Şafak Akın, İlknur Öztürk Ünsal, Mustafa Özbek · 2017 · Journal of the Turkish-German Gynecological Association
23. Increased Risk of Polycystic Ovary Syndrome in Taiwanese Women with Chronic Periodontitis: A Nationwide Population-Based Retrospective Cohort Study
    Ching Tong, Yu‐Hsun Wang, Hui‐Chieh Yu, Yu‐Chao Chang · 2019 · Journal of Women s Health
24. Increased DHEAS and Decreased Total Testosterone Serum Levels in a Subset of Men with Early-Onset Androgenetic Alopecia: Does a Male PCOS-Equivalent Exist?
    Rossella Cannarella, Rosita Angela Condorelli, Federica Dall’Oglio, Sandro La Vignera, Laura M. Mongioì, Giuseppe Micali, Aldo Eugenio Calogero · 2020 · International Journal of Endocrinology
25. C-reactive protein and homocysteine levels are associated with abnormal heart rate recovery in women with polycystic ovary syndrome
    Cemil Kaya, Ebru Akgül, Recai Pabuçcu · 2009 · Fertility and Sterility
26. Prevalence and characteristics of polycystic ovarian syndrome in a sample of infertile Kurdish women attending IVF infertility center in maternity teaching hospital of Erbil City
    Bayan Hussein, Shahla Alalaf · 2013 · Open Journal of Obstetrics and Gynecology
27. Impact of body mass index on blood pressure levels in patients with polycystic ovary syndrome
    Cristiano Roberto Grimaldi Barcellos, Michelle P. Rocha, Sylvia Asaka Yamashita Hayashida, Décio Mion, Silvia G. Lage, José Antônio Miguel Marcondes · 2007 · Arquivos Brasileiros de Endocrinologia & Metabologia
28. Adropin levels in women with polycystic ovaries undergoing ovarian stimulation: correlation with lipoprotein lipid profiles
    Artemis Bousmpoula, Evangelia E. Kouskouni, Evangelos Benidis, Styliani Demeridou, Rachil Kapeta-Kourkouli, Anthia Chasiakou, Stavroula G. Baka · 2017 · Gynecological Endocrinology
29. Hemodynamic alterations and wall properties in large arteries of young, normotensive, and non-obese women with polycystic ovary syndrome
    Eftihios Trakakis, Alexia P. Balanika, Christos S. Baltas, C. Loghis, George Simeonidis, Vassilios Vaggopoulos, Olympia Papakonstantinou, Athanassios D. Gouliamos, George Salamalekis, Dimitrios Kassanos · 2008 · Journal of Endocrinological Investigation
30. Obesity and insulin resistance in women with polycystic ovary syndrome
    Chun-Sen Hsu, Chien‐Hua Wu, Chiu Wan-Chun, Lee Ching-Tzu, Chun-Jen Chang, Hsu Ming-I · 2010 · Gynecological Endocrinology
31. Fibroblast growth factor 21 and its relation to metabolic parameters in women with polycystic ovary syndrome
    Serap Baydur Şahin, Teslime Ayaz, Medine Cumhur Cüre, Hacer Sezgin, Ülkü Mete Ural, Gülşah Balık, Figen Kır Şahin · 2014 · Scandinavian Journal of Clinical and Laboratory Investigation
32. Evidence for increased cardiovascular events in the fathers but not mothers of women with polycystic ovary syndrome
    Mary C. Taylor, A. Reema Kar, Allen R. Kunselman, Christy Stetter, Andrea Elizabeth Dunaif, Richard S. Legro · 2011 · Human Reproduction
33. Body weight reduction and metformin: Roles in polycystic ovary syndrome
    AL-Nozha, Omar, Habib, Fawziah, Mojaddidi, Moaz, El-Bab, Mohamed Fath · 2013 · Pathophysiology
34. Comprehensive Meta-Analysis of Functional and Structural Markers of Subclinical Atherosclerosis in Women with Polycystic Ovary Syndrome
    Dandan Sun, Yu‐Peng Wu, Mingyan Ding, Fang Zhu · 2022 · Angiology
35. Identification of key biomarkers for predicting atherosclerosis progression in polycystic ovary syndrome via bioinformatics analysis and machine learning
    Wenjing Zhang, Yalin Wu, Yalin Yuan, Leigang Wang, Bing Yu, Xin Li, Zhong Yao, Bin Liang · 2024 · Computers in Biology and Medicine
36. 4G/5G Polymorphism of PAI-1 gene and Alu-repeat I/D polymorphism of TPA gene in Turkish patients with polycystic ovary syndrome
    Muammer Karadeniz, Mehmet Erdoğan, Afig Berdeli, Füsun Saygılı, Candeğer Yılmaz · 2007 · Journal of Assisted Reproduction and Genetics
37. Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome
    Krystallenia Alexandraki, Eleitho Practice, Athens, Greece, Eleni Kandaraki, Kalliopi‐Anna Poulia, Christina Piperi, Eirini Papadimitriou, Theo Papaioannou · 2021 · touchREVIEWS in Endocrinology
38. Oxidative stress markers are not valuable markers in lean and early age of polycystic ovary syndrome patients.
    E Cakir, Mustafa Özbek, E Ozkaya, Nujen Çolak, Erman Çakal, Müyesser Saykı, Aşkın Güngüneş, Yüksel Aliyazıcıoğlu, Ahmet Menteşe, Tuncay Delibaşı · 2011 · PubMed
39. A combined treatment with myo-inositol and monacolin K improve the androgen and lipid profiles of insulin-resistant PCOS patients
    Maria Concetta Musacchio, Vincenzo De Leo · 2013 · Journal of Metabolic Syndrome
40. Sex hormones and the risk of myocardial infarction in women and men: a prospective cohort study in the UK Biobank
    Katie Harris, Sanne A. E. Peters, Mark Woodward · 2023 · Biology of Sex Differences
41. The PON1–108C/T polymorphism, and not the polycystic ovary syndrome, is an important determinant of reduced serum paraoxonase activity in premenopausal women
    José L. San Millán, Francisco Álvarez‐Blasco, Manuel Luque‐Ramírez, José Ignacio Botella-Carretero, Héctor Francisco Escobar-Morreale · 2006 · Human Reproduction
42. Diagnóstico del Síndrome de Ovario Poliquístico: nuevos fenotipos, nuevas incógnitas
    Paulina M. Merino, Carolina Schulin-Zeuthen P, Ethel Codner D · 2009 · Revista médica de Chile
43. The Effect of Palm Pollen Extract on Polycystic Ovary Syndrome (POS) in Rats
    Hojatollah Karimi Jashni, Hossein Kargar Jahromi, Zahra Bagheri · 2016 · DOAJ (DOAJ: Directory of Open Access Journals)
44. Polycystic Ovary Syndrome and Gender Identity.
    Minghao Liu, Swetha Murthi, Leonid Poretsky · 2020 · PubMed Central
45. Association of polycystic ovary syndrome with cardiovascular risk factors
    Tanzeela Akram, Shahid Hasan, Muhammad Imran, Asima Karim, Muhammad Arslan · 2009 · Gynecological Endocrinology
46. Association of the T45G and G276T polymorphisms in the adiponectin gene with PCOS: A meta-analysis
    Lingling Gao, Yuan Zhang, Yugui Cui, Yaqin Jiang, Xinru Wang, Jiayin Liu · 2011 · Gynecological Endocrinology
47. Ethinyl estradiol–drospirenone vs ethinyl estradiol–drospirenone plus metformin in the treatment of lean women with polycystic ovary syndrome
    Neşe Çınar, Ayla Harmancı, Miyase Bayraktar, Bülent Okan Yıldız · 2012 · Clinical Endocrinology
48. Increased circulating soluble P-selectin in polycystic ovary syndrome
    Bülent Okan Yıldız, Gürkan Bozdağ, Ayla Harmancı, Umit Otegen, K. Boynukalin, Zehra Vural, Şerafettin Kirazlı, İbrahim C. Haznedaroğlu, Hakan Yaralı́ · 2009 · Fertility and Sterility
49. Estrogen Deprivation and Myocardial Infarction: Role of Aerobic Exercise Training, Inflammation and Metabolomics
    Olívia Moraes Ruberti, Bruno Lima Rodrigues · 2019 · Current Cardiology Reviews
50. Steroids and the metabolic syndrome
    Renato Pasquali, Valentina Vicennati · 2008 · The Journal of Steroid Biochemistry and Molecular Biology
51. Genome-Wide Association Studies and Risk Scores for Coronary Artery Disease: Sex Biases
    Sean Byars, Mike Inouye · 2018 · Advances in experimental medicine and biology
52. Recent advances in the treatment of polycystic ovary syndrome
    Bülent Okan Yıldız · 2004 · Expert Opinion on Investigational Drugs
53. Evaluation of Para- and Perirenal Fat Thickness and its Association with Metabolic Disorders in Polycystic Ovary Syndrome
    Serap Baydur Şahin, Tuğba Durakoğlugil, Teslime Ayaz, Osman Zikrullah Şahin, Murtaza Emre Durakoğlugil, Fatih Sümer, Ezgi Aktaş, Nese Alyildiz · 2015 · Endocrine Practice
54. Association of methylenetetrahydrofolate reductase gene C677T polymorphism with polycystic ovary syndrome risk: a systematic review and meta-analysis update
    Liyuan Fu, Limeng Dai, Xiao-gang Li, Kun Zhang, Yun Bai · 2013 · European Journal of Obstetrics & Gynecology and Reproductive Biology
55. Insulin-like growth factor 1, liver enzymes, and insulin resistance in patients with PCOS and hirsutism
    Evrim Çakır, Oya Topaloğlu, Nujen Çolak Bozkurt, Başak Karbek, Aşkın Güngüneş, Müyesser Saykı Arslan, İlknur Öztürk Ünsal, Esra Tutal, Bekir Uçan, Tuncay Delibaşı · 2014 · TURKISH JOURNAL OF MEDICAL SCIENCES
56. Heart rate variability in normal-weight patients with polycystic ovary syndrome
    Celal Kılıt · 2017 · The Anatolian Journal of Cardiology
57. Serum and follicular fluid irisin levels in women with polycystic ovaries undergoing ovarian stimulation: correlation with insulin resistance and lipoprotein lipid profiles
    Artemis Bousmpoula, Evangelos Benidis, Styliani Demeridou, Rachil Kapeta-Kourkouli, Anthia Chasiakou, Stamatia Chasiakou, Evangelia E. Kouskouni, Stavroula G. Baka · 2019 · Gynecological Endocrinology
58. Does hyperandrogenism have an effect on hearing loss in patients with polycystic ovary syndrome?
    Fatih Oğhan, Hakan Çoksüer · 2011 · Auris Nasus Larynx
59. Polycystic Ovarian Syndrome: the Next Cardiovascular Dilemma in Women?
    Preethi Srikanthan, Stanley G. Korenman, Susan Stanik Davis · 2006 · Endocrinology and Metabolism Clinics of North America
60. Association of IL-18 genotype with impaired glucose regulation in Korean women with polycystic ovary syndrome
    Ji Won Kim, Min Ho Lee, Ji Eun Park, Tae Ki Yoon, Woo Sik Lee, Sung Han Shim · 2012 · European Journal of Obstetrics & Gynecology and Reproductive Biology
61. Biomediators in Polycystic Ovary Syndrome and Cardiovascular Risk
    S. Pandurevic, Djuro Μacut, Flaminia Fanelli, Uberto Pagotto, Alessandra Gambineri · 2021 · Biomolecules
62. FREQUENCY OF POLY CYSTIC OVARY SYNDROME IN PATIENTS WITH PREMENOPAUSAL BREAST CANCER
    Nasrin Ghasemi, Mohammad Reza Mortazavizadeh, Aboolfazl Khorasani · 2010 · TSpace (University of Toronto)
63. Optimal Waist Circumference for Prediction of Metabolic Syndrome in Young Korean Women With Polycystic Ovary Syndrome
    Jee Young Oh, Yeon‐Ah Sung, Hye Jin Lee, Ji Young Oh, Hye Won Chung, Hyesook Park · 2009 · Obesity
64. HEART RATE VARIABILITY AND LIPID PROFILE IN NON OBESE YOUNG INDIAN WOMEN WITH POLYCYSTIC OVARY SYNDROME
    Malathi Balamurugan, Malathi Balamurugan, Gomathi Ramanathan · 2015 · Journal of Evolution of Medical and Dental Sciences
65. Characteristics of 250 reproductive-aged polycystic ovary syndrome Thai women at Siriraj Hospital.
    Thanyarat Wongwananuruk, Suchada Indhavivadhana, Manee Rattanachaiyanont, Kitirat Techatraisak, Pichai Leerasiri, Prasong Tanmahasamut, Surasak Angsuwathana, Chongdee Dangrat · 2010 · PubMed
66. The frequency of metabolic syndrome in women with polycystic ovaries at reproductive age and comparison of different diagnostic criteria for metabolic syndrome
    Eray Çalışkan, Teomant Kılıç, Harika Bodur, Şahin Zeteroğlu · 2007
67. Metabolic Syndrome and Its Characteristics among Reproductive-Aged Women with Polycystic Ovary Syndrome: A Cross-sectional Study in Northwest Iran.
    Fatemeh Pourteymour Fard Tabrizi, Beitollah Alipoor, Mahzad Mehrzad Sadaghiani, Alireza Ostadrahimi, Aida Malek Mahdavi · 2013 · Europe PMC (PubMed Central)
68. Gingival crevicular fluid levels of visfatin in patients with chronic periodontitis and polycystic ovary syndrome
    Forouzan Saljoughi, Khadijeh Nasri, Mojtaba Bayani · 2020 · Obstetrics & Gynecology Science
69. Association of Gly972Arg variant of insulin receptor subtrate-1 and Gly1057Asp variant of insulin receptor subtrate-2 with polycystic ovary syndrome in the Chinese population
    Ming‐Wei Lin, Mei‐Feng Huang, Meng‐Hsing Wu · 2014 · Journal of Ovarian Research
70. Hyperhomocysteinaemia is associated with biochemical hyperandrogenaemia in women with reproductive age
    Yi-Hui Lin, Shih‐Yi Huang, Ming-I Hsu, Yuan‐chin Ivan Chang, Chih-Yu Cheng, Chun-Sen Hsu, Chii‐Ruey Tzeng · 2013 · European Journal of Obstetrics & Gynecology and Reproductive Biology
71. Diagnosis of Polycystic Ovary Syndrome using Machine Learning Algorithms
    Mr. Abdul Khadar A, M S Shreasta, Nilesh S. Vani, K R Vathsala, Vidhya Shree V N · 2022 · International Journal of Advanced Research in Science Communication and Technology
72. The Effects of Rosiglitazone, Metformin, and Estradiol-Cyproterone Acetate on Lean Patients With Polycystic Ovary Syndrome
    Şevki Çetinkalp, Muammer Karadeniz, Mehmet Erdoğan, Gökhan Özgen, Füsun Saygl, Candeger Ylmaz · 2009 · The Endocrinologist
73. Heart type fatty acid binding protein response and subsequent development of atherosclerosis in insulin resistant polycystic ovary syndrome patients
    Evrim Çakır, Mustafa Özbek, Mustafa Şahi̇n, Erman Çakal, Aşkın Güngüneş, Zeynep Giniş, Taner Demirci, Tuncay Delibaşı · 2012 · Journal of Ovarian Research
74. Understanding polycystic ovarian syndrome pathogenesis: an updated of its genetic aspects.
    Aldo Eugenio Calogero, Viola Calabrò, M. Catanuso, Rosita Angela Condorelli, Sandro La Vignera · 2011 · PubMed
75. Thyroid Function and Volume are Associated with Anthropometric Measurements and Insulin Resistance in Egyptian Women with Polycystic Ovary Syndrome
    Mohamed M Elrakhawy Sherin Abd El-Aziz, Mervat M. El-Eshmawy · 2013 · Journal of Diabetes & Metabolism
76. Fetal androgen excess provides a developmental origin for polycystic ovary syndrome
    Abbott, David H, Dumesic, Daniel A · 2009 · Expert Review of Obstetrics & Gynecology
77. Amenorrhea, Anovulation, and Dysfunctional Uterine Bleeding
    Peter J. Illingworth · 2010 · Elsevier eBooks
78. Female Infertility and Cardiovascular Risk - A Hype or an Underestimated Reality?
    Julia Κ. Bosdou, Panagiotis G. Anagnostis, George T. Lainas, Efstratios Michaelis Kolibianakis · 2020 · Current Pharmaceutical Design
79. Progesterone levels on the hCG day and outcomes in vitro fertilization in women with polycystic ovary syndrome
    Cuiying Peng, Zifen Guo, Xingyu Long, Guangxiu Lu · 2012 · Journal of Assisted Reproduction and Genetics
80. Le syndrome des ovaires polykystiques (SOPK)
    Antoine Torre, Hervé Fernandez · 2007 · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction
81. Salivary Interleukin-6 Levels among Polycystic Ovary Syndrome Patients with and Without Chronic Periodontitis – A Comparative Study
    Arun Varghese, Pratebha Balu, Saravanakumar Ravindran, Jananni Muthu, K Vineela · 2019 · Contemporary Clinical Dentistry
82. No relationship between osteoprotegerin concentrations and endothelial dysfunction in non-obese women with and without polycystic ovary syndrome
    Remzi Abalı, Nicel Taşdemir, Şeref Alpsoy, Ufuk Göker Tasdemir, Savaş Güzel, Mehmet Aytaç Yüksel, İlkbal Temel Yüksel, Murat Yılmaz · 2014 · Archives of Gynecology and Obstetrics
83. The progesterone receptor PROGINS polymorphism is not related to oxidative stress factors in women with polycystic ovary syndrome
    Muammer Karadeniz, Mehmet Erdoğan, Afig Berdelı, Sadık Tamsel, Füsun Saygılı, Candeğer Yılmaz · 2007 · Cardiovascular Diabetology
84. Associations between cardiovascular health and female infertility: A national population-based study
    Meiyan Luo, Jianshu Li, Xiangjun Xiao, Ping Wu, Ya Zhang · 2024 · PLoS ONE
85. Trend changes and factor analysis of endometrial hyperplasia in patients with polycystic ovarian syndrome based on the Korean National Health Insurance Database
    Bora Park, Hakmo Lee, Suyeon Park, Eun Sil Lee, Jeong Jae Lee, Young Lee, Je Hyun Seo · 2022 · BMC Women s Health
86. Effect of Short-Term Standard Therapeutic Regimens on Neuropeptide Y and Adipose Tissue Hormones in Overweight Insulinresistant Women with Polycystic Ovary Syndrome
    M. Orbetzova, B. Pehlivanov, M. Mitkov, I. Atanassova, Z. Kamenov, Georgi Kolarov, G. Genchev · 2011 · Folia Medica
87. L’insulinorésistance biologique chez la femme congolaise avec syndrome des ovaires polymicrokystiques (SOPK)
    Chantal Anifa Amisi, L Mputu, EJ Mboloko, E. Bieleli, P. Pozzili · 2013 · Gynécologie Obstétrique & Fertilité
88. Pregnancy outcomes, reproductive history and cardiovascular disease risk in women: What do we know and what is needed?
    Janet Wei, Margo Minissian, C. Noel Bairey Merz · 2016 · European Journal of Preventive Cardiology
89. Unmasking the morphological alteration of erythrocytes among women suffering from PCOS
    Sutithi Dey, Ipsita Chakraborty, Payel Biswas, Ayantika Paul, Pratip Chakraborty, Rajen Haldar · 2024 · Blood Cells Molecules and Diseases
90. Polycystic ovary syndrome as a developmental disorder
    Angelique J. Goverde, Hendrika E. Westerveld, Susanne M. Veltman-Verhulst, Bart C.J.M. Fauser · 2008 · Expert Review of Obstetrics & Gynecology
91. G276T polymorphism in the ADIPOQ gene is associated with a reduced risk of polycystic ovarian syndrome: A meta-analysis of Asian population
    Raphael Enrique Tiongco, Franzielle Jowe Cabrera, Benjie Clemente, Chastene Christopher Flake, Micah Angela Salunga, Maria Ruth Pineda-Cortel · 2019 · Taiwanese Journal of Obstetrics and Gynecology
92. Cardiovascular evaluation and serum paraoxonase-1 levels in adolescents with polycystic ovary syndrome
    Mecnun Çetin, Perihan Tunçdemir, Kamuran Karaman, Servet Yel, Erbil Karaman, Mesut Özgökçe, Ahmet Ufuk Kömüroğlu · 2019 · Journal of Obstetrics and Gynaecology
93. Polycystic Ovary Syndrome
    Minisha Sood, Susan B. Zweig, Marsha C. Tolentino, Marina Strizhevsky, Leonid Poretsky · 2015 · Springer eBooks
94. Polycystic Ovary Syndrome in Korean Women: Clinical Characteristics and Diagnostic Criteria
    Yeon‐Ah Sung · 2011 · Endocrinology and Metabolism
95. The polycystic ovary syndrome: an example of obesity-related cardiovascular complication affecting young women
    Francesco Orio, Teresa Cascella, Francesco Giallauria, Stefano Palomba, Anna De Lorenzo, Rosa Lucci, Elena Ambrosino, Gaetano Lombardi, Annamaria Colao, Carlo Vigorito · 2016 · Monaldi Archives for Chest Disease
96. Evaluation of carotid wall thickness and vertebro‐basilar system insufficiency in patients with obese polycystic ovary syndrome
    Hakan Çoksüer, Mustafa Koplay, Fatih Oğhan, Berna Haliloğlu, Nadi Keskın · 2011 · Journal of obstetrics and gynaecology research
97. Microbial harmony in female reproductive health: exploring the impact of intestinal flora on ovarian function and disease pathogenesis
    Xiaoyan Luo · 2024 · American Journal of Translational Research
98. The Association of -429T>C and -374T>A Polymorphisms in the RAGE Gene with Polycystic Ovary Syndrome
    Junghyun Park, Lan Li, Jin-Woo Choi, Kwang‐Hyun Baek · 2016 · International Journal of Medical Sciences
99. Diffuse idiopathic skeletal hyperostosis in a 33-year-old woman with PCOS and metabolic syndrome: a rare scenario
    Jojin Jose Chitten, Boblee James · 2019 · BMJ Case Reports
100. Sindrom polikistoznykh yaichnikov i metabolicheskiy sindrom
     Ivan Ivanovich Dedov, С А Бутрова · 2006 · Obesity and metabolism